Image 1-ZEPOSIA (Ozanimod) - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

ZEPOSIA (Ozanimod) for the Treatment of Multiple Sclerosis

Image 1-ZEPOSIA (Ozanimod)
Zeposia is indicated for the treatment of relapsing forms of multiple sclerosis (MS). Credit: Bristol Myers Squibb.